Hemoshear Biopharma To Participate In Panel Discussion On Investment Opportunities In China Hosted By Duane Morris And The Chinese Biopharmaceutical Equipment & Supplies
1 equipment items found
Manufactured by:HemoShear Therapeutics, Inc. based inCharlottesville, VIRGINIA (USA)
HST5040 is an investigational small molecule therapy being developed by HemoShear to reduce the levels of toxins associated with methylmalonic acidemia (MMA) and propionic acidemia (PA), rare genetic disorders caused by the de?ciency of certain enzymes required to metabolize amino acids. HST5040 is formulated for convenient daily administration at home as a liquid taken either orally or through a ...